Reference
US Food and Drug Administration. Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin) Internet Document : 14 Jan 2020. Available from: URL: https://www.fda.gov/drugs/drug-safety-and-availability/safety-clinical-trial-shows-possible-increased-risk-cancer-weight-loss-medicine-belviq-belviq-xr
Rights and permissions
About this article
Cite this article
US public warned of potential cancer risk with lorcaserin. Reactions Weekly 1788, 1 (2020). https://doi.org/10.1007/s40278-020-74124-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-74124-9